Help for PCOS? — Myo-Inositol May Support the Menstrual Cycle, Ovulation, and Fertility!
Laura Chrobok 01.07.2026
Irregular menstrual cycles, absent ovulation and difficulty conceiving affect many women with polycystic ovary syndrome (PCOS). Anyone looking for natural ways to support hormonal balance will almost inevitably come across myo-inositol, a naturally occurring sugar alcohol (polyol). But can it really help regulate the menstrual cycle, promote ovulation or reduce insulin resistance, a common feature of PCOS?
Here you will find out what myo-inositol is, how it works in the body and what current scientific studies say about the potential benefits of myo-inositol supplements.
What Is Myo-Inositol and What Do We Need It For?
Myo-inositol is the most abundant form of inositol (cyclic sugar alcohols/polyols) found in the human body. Our bodies can produce myo-inositol on its own, but it can (and should) also be obtained through foods and dietary supplements.
Natural food sources of myo-inositol include:
o beans
o citrus fruits
o whole grains
o nuts
o seeds
(Clements & Darnell, 1980).
However, the amounts found in foods are generally far below the 2–4 g per day commonly investigated in scientific studies.
Within our cells, myo-inositol performs important signalling functions. Among other roles, it forms part of so-called second messenger systems, which are involved in the actions of insulin and follicle-stimulating hormone (FSH). For this reason, myo-inositol has been intensively studied for many years in relation to metabolic disorders and polycystic ovary syndrome (PCOS) (Croze & Soulage, 2013; Fitz et al., 2024).
Myo-Inositol for PCOS?
PCOS is a complex hormonal and metabolic disorder whose exact cause has not yet been fully clarified. Current evidence suggests that genetic factors, hormonal changes and, in many cases, insulin resistance all play important roles. These factors can disrupt hormonal balance, preventing eggs from maturing regularly or ovulation from occurring.
PCOS is one of the most common hormonal disorders affecting women of reproductive age. Depending on the diagnostic criteria used, it is estimated to affect 6–13% of women worldwide (Teede et al., 2023).
Common complaints include:
· irregular or absent menstrual periods
· absent ovulation
· infertility
· elevated androgen levels
· acne or excessive body hair growth
An insulin resistance may influence hormonal processes, thereby contributing to menstrual irregularities and absent ovulation. Because myo-inositol is involved in insulin-dependent signalling pathways, researchers are investigating whether supplementation may positively influence both metabolism and reproductive function.
o Myo-Inositol As A Support the Menstrual Cycle, Ovulation, and Pregnancy?
This question is at the centre of numerous scientific studies. Several systematic reviews and meta-analyses report evidence suggesting that myo-inositol may improve various cycle-related parameters in women with PCOS. Reported findings include more frequent ovulation and improvements in certain hormonal and metabolic markers (Greff et al., 2023).
The International Evidence-Based PCOS Guideline explicitly refers to inositol—including myo-inositol—as a possible treatment option. However, it also concludes that the current evidence remains limited. The same applies to the question of whether myo-inositol can improve the chances of conception (Fitz et al., 2024; Teede et al., 2023). As is so often the case, it is said that further studies are needed to allow a reliable assessment of its effectiveness. One can therefore only hope that research continues diligently. In the meantime, however, you, dear readers, can of course continue to gather information for yourselves ...
Myo-Inositol for Insulin Resistance?
Many women with PCOS experience insulin resistance. Because myo-inositol plays an important role in insulin signalling, numerous studies have investigated its effects on glucose metabolism. Meta-analyses have reported improvements in certain metabolic parameters, including fasting insulin levels and HOMA-IR (Greff et al., 2023).
These findings are regarded as promising but are not yet considered definitive.
o Is Myo-Inositol Better Than Metformin for PCOS?
Metformin is one of the most commonly prescribed medications for insulin resistance and is frequently used in women with PCOS.
When compared with metformin, myo-inositol has produced partly comparable results in some studies and has often been better tolerated, particularly with regard to gastrointestinal side effects (Fitz et al., 2024; Greff et al., 2023).
Nevertheless, myo-inositol should not be regarded as a substitute for individually indicated medical treatment.
Why Do Many Myo-Inositol Supplements Also Contain D-Chiro-Inositol?
Besides myo-inositol, other forms of inositol exist, particularly D-chiro-inositol. Both perform different functions within cellular signalling pathways. For this reason, many manufacturers combine both forms in a single supplement.
Forms and Dosage of Myo-Inositol
Myo-inositol is mainly available as a powder or in capsule form.
Scientific studies have commonly investigated doses of 2–4 g per day. In some studies, myo-inositol was combined with D-chiro-inositol. The most appropriate dosage depends on the specific product and the individual's situation. Therefore, the manufacturer's instructions and, where appropriate, medical advice should always be followed.
Can Myo-Inositol Cause Side Effects?
Overall, myo-inositol is considered to be well tolerated. Compared with metformin, some studies have reported fewer gastrointestinal side effects. Nevertheless, dietary supplements may also cause side effects or may not be suitable for everyone. Women trying to conceive or those with existing medical conditions should therefore discuss supplementation with their physician..
Conclusion on Myo-Inositol: This Can Be Concluded from the Current Evidence
Myo-inositol is currently one of the best-studied dietary supplements for PCOS. The available evidence suggests that it may particularly benefit women with menstrual irregularities, absent ovulation or insulin resistance. At the same time, current research shows that many questions remain unanswered and that further high-quality studies are still needed.
Nevertheless, because of its biological functions and the largely positive findings reported so far, myo-inositol has become one of the most promising naturopathic approaches for PCOS. Whether supplementation is appropriate, however, should always be decided on an individual basis.
FAQ — Frequently Asked Questions About Myo-Inositol
1. Does myo-inositol need to be taken long term?
Whether long-term supplementation is appropriate cannot be answered universally. Most clinical studies have investigated myo-inositol over several weeks or months. The appropriate duration depends on individual symptoms, treatment goals and medical advice.
2. Can myo-inositol be taken together with metformin?
Scientific studies have investigated both myo-inositol alone and in combination with metformin. Whether combined use is appropriate should always be decided individually and in consultation with a healthcare professional.
3. Can lean women with PCOS also benefit from myo-inositol supplementation?
Yes, PCOS does not occur exclusively in women who are overweight. Women of normal weight may also be affected. However, because symptoms and metabolic changes vary considerably between individuals, it is not possible to predict whether myo-inositol will benefit every woman to the same extent.
Further information on metabolic conditions, hormonal conditions (such as endometriosis) and many other topics can be found not only on our blog, but also in our “Medizinskandale” book series and the “Codex Humanus” — the fifth volume of which was recently published. Feel free to visit our online shop.
Sources:
· Clements, R. S. Jr.; Darnell, B. (1980): “Myo-Inositol Content of Common Foods: Development of a High-Myo-Inositol Diet,” The American Journal of Clinical Nutrition.
· Croze, M. L.; Soulage, C. O. (2013): “Potential Role and Therapeutic Interests of Myo-Inositol in Metabolic Diseases,” Biochimie.
· Fitz, V. et al. (2024): “Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-Based PCOS Guidelines,” Journal of Clinical Endocrinology & Metabolism.
· Teede, H. J. et al. (2023): “International Evidence-Based Recommendations for Polycystic Ovary Syndrome in Adolescents,” Journal of Clinical Endocrinology & Metabolism.
· Greff, D. et al. (2023): “Inositol is an Effective and Safe Treatment in Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis of Randomized Controlled Trials,” Reproductive Biology and Endocrinology.